CVA
SEM

Ceredex Value Advisors’s Select Medical SEM Stock Holding History

Ceredex Value Advisors’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-267,150
Closed -$5.04M – 177
2024
Q4 		$5.04M Sell
267,150
-197,500
-43% -$3.81M 0.1% 159
2024
Q3 		$8.73M Sell
464,650
-141,798
-23% -$2.72M 0.17% 143
2024
Q2 		$11.5M Buy
+606,448
New +$10.3M 0.22% 122

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ceredex Value Advisors's SEM Position: Q1 2025 in Review

Ceredex Value Advisors sold out of Select Medical (SEM) in Q1 2025, closing a stake of 267,150 shares — an estimated $5.04M sold.

Ceredex Value Advisors first reported a position in SEM in Q2 2024 and held it in 3 quarters. The position peaked at $11.5M in Q2 2024. 274 funds tracked by Wall St. Rank hold SEM as of Q1 2025.

  • Ceredex Value Advisors reported no remaining Select Medical position as of Q1 2025 after selling out during the quarter.
  • Ceredex Value Advisors sold 267,150 Select Medical shares in Q1 2025, an estimated $5.04M.
  • Ceredex Value Advisors first reported a position in Select Medical in Q2 2024 and held it in 3 quarters.
  • Ceredex Value Advisors's Select Medical position peaked at $11.5M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Select Medical as of Q1 2025.

Based on Ceredex Value Advisors's 13F filing for Q1 2025, filed 14 May 2025.